- In Vitro Models for Drug Screening
Drug discovery is a process where a new drug or medications are discovered and aims to identify a compound therapeutically useful in curing and treating disease. It includes a wide range of scientific divisions, including biology, chemistry, and pharmacology.
This process associates with the identification of candidates, synthesis, characterization, validation, optimization, screening, and assays for therapeutic efficacy.
The three major phases are:
- Formulation,
- Delivery,
- Packaging Development
Drug Development Phases includes:
- Phase 1: Discovery and Development.
- Phase 2: Preclinical Research.
- Phase 3: Clinical Research.
- Phase 4: FDA Review.
- Phase 5: FDA Post-Market Safety Monitoring.
Drug screening is a process where potential drugs are identified and optimized before the selection of a candidate drug to progress to clinical trials. It can involve screening large volumes of chemicals for a particular biological activity in high-throughput screening assays.
Drug screening mainly includes In-vivo and In-vivo models for drug screening
Sergey Suchkov
Sechenov University and Moscow Engineering Physical Institute, Russia
Esmaiel Jabbari
University of South Carolina, USA
Marino Nebuloni
Parma University, Italy
Daniela Monti
University of Pisa, Italy
Jan Versijpt
University Hospital Brussels, Belgium
Madhav Bhatia
University of Otago, New zealand
Stefanie Santos
University Hospital Zurich, Switzerland
Dmitry Ustyuzhanin
National Medical Research Center of Cardiology, Russia
Anna Caprifico
Kingston University, UK
Annalisa Dalmoro
University of Salerno, ItalySubmit your abstract Today
Title : Drug Delivery to Stem Cells in Regenerative Medicine
Esmaiel Jabbari, University of South Carolina, USA
Title : Targeted nanoparticles for diagnostic and theranostic applications
Paul Millner, University of Leeds, UK
Title : Nanostructured Formulations in Skin Cancer: Challenges and Perspectives
Daniela Monti, University of Pisa, Italy
Title : Introducing the Sorush Cancer Treatment Protocol (SCTP)
Sorush Niknamian, Violet Cancer Institute, USA
Title : Hydrogen Sulfide: A Stinky Gas….. and Novel Therapeutic Target for Inflammatory Disease
Madhav Bhatia, University of Otago, Newzealand
Title : Assessment an umbilical cells induced neuroplasticity in patients with schizophrenia using functional MRI
Dmitry Ustyuzhanin, National Medical Research Center of Cardiology, Russia
Title : Evaluation of drug permeability in blood-brain barrier in vitro models
Anna Caprifico, Kingston University, UK
Title : Bryophyllum pinnatum Compounds Inhibit the Oxytocin-Induced Pathways in Human Myometrial Cells
Stefanie Santos, University Hospital Zurich, Switzerland
Title : Cancer: is there any hope?
Ranjita Shegokar, Capnomed GmbH, Germany
Title : Process innovation in the production of smart lipid-polymeric release systems
Annalisa Dalmoro, University of Salerno, Italy